Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD Year: 2015
Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Both moderate and severe exacerbations accelerate physical activity decline in COPD patients Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017 Year: 2018
Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
The distinctive effect of fatigue in defining exercise intolerance and depression in moderate stable COPD, Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009
Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Speed of recovery after antibiotic treatment of acute exacerbations of moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations Source: Eur Respir J 2013; 41: 815-823 Year: 2013
The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002
Impact of stable state symptoms on the future burden of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Effect of depression and anxiety on the risk of exacerbation and hospitalization in COPD Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008
The EQ-5D is responsive to recovery from a moderate COPD exacerbation Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013
The longitudinal association of daily physical activity and symptoms of exacerbations in COPD patients Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017
Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016